The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published in Genes & Diseases.
EZH2 Inhibition Offers Hope for Fighting Treatment-Resistant Cancers
- Post author:admin
- Post published:March 8, 2025
- Post category:uncategorized